Algernon Pharmaceuticals Inc. AGN.CN Stock
Algernon Pharmaceuticals Inc. Price Chart
Algernon Pharmaceuticals Inc. AGN.CN Financial and Trading Overview
| Algernon Pharmaceuticals Inc. stock price | 0.1 CAD |
| Previous Close | 0.23 CAD |
| Open | 0 CAD |
| Bid | 0.22 CAD x 0 |
| Ask | 0.24 CAD x 0 |
| Day's Range | 0 - 0 CAD |
| 52 Week Range | 0 - 1.74 CAD |
| Volume | 0 CAD |
| Avg. Volume | 24.97K CAD |
| Market Cap | 2.65M CAD |
| Beta (5Y Monthly) | 0.388167 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.28 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.56 CAD |
AGN.CN Valuation Measures
| Enterprise Value | 2M CAD |
| Trailing P/E | N/A |
| Forward P/E | -0.4107143 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.6182796 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.342 |
Trading Information
Algernon Pharmaceuticals Inc. Stock Price History
| Beta (5Y Monthly) | 0.388167 |
| 52-Week Change | -78.14% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.74 CAD |
| 52 Week Low | 0 CAD |
| 50-Day Moving Average | 0.24 CAD |
| 200-Day Moving Average | 0.57 CAD |
AGN.CN Share Statistics
| Avg. Volume (3 month) | 24.97K CAD |
| Avg. Daily Volume (10-Days) | 23.62K CAD |
| Shares Outstanding | 11.52M |
| Float | 8.61M |
| Short Ratio | 0.03 |
| % Held by Insiders | 3.22% |
| % Held by Institutions | 14.39% |
| Shares Short | 631 |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.010% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 4:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | August 31, 2022 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | August 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -53.43% |
| Return on Equity (ttm) | -123.79% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -5851840 CAD |
| Net Income Avi to Common (ttm) | -6145317 CAD |
| Diluted EPS (ttm) | -0.63 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 220.59K CAD |
| Total Cash Per Share (mrq) | 0.02 CAD |
| Total Debt (mrq) | 0 CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.195 |
| Book Value Per Share (mrq) | 0.372 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3648917 CAD |
| Levered Free Cash Flow (ttm) | -1088101 CAD |
Profile of Algernon Pharmaceuticals Inc.
| Country | Canada |
| State | BC |
| City | Vancouver |
| Address | 601 West Broadway |
| ZIP | V5Z 4C2 |
| Phone | N/A |
| Website | https://algernonpharmaceuticals.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of nonalcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada, Australia, and New Zealand. The company's pipeline includes Ifenprodil, which completed Phase 2 clinical trial for the treatment of idiopathic pulmonary fibrosis and chronic cough; repirinast, which is in preclinical stage for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine, which has completed preclinical stage for the treatment of strokes. The company was formerly known as Breathtec Biomedical, Inc. and changed its name to Algernon Pharmaceuticals Inc. in July 2015. Algernon Pharmaceuticals Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Q&A For Algernon Pharmaceuticals Inc. Stock
What is a current AGN.CN stock price?
Algernon Pharmaceuticals Inc. AGN.CN stock price today per share is 0.1 CAD.
How to purchase Algernon Pharmaceuticals Inc. stock?
You can buy AGN.CN shares on the Canadian Sec exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Algernon Pharmaceuticals Inc.?
The stock symbol or ticker of Algernon Pharmaceuticals Inc. is AGN.CN.
Which industry does the Algernon Pharmaceuticals Inc. company belong to?
The Algernon Pharmaceuticals Inc. industry is Biotechnology.
How many shares does Algernon Pharmaceuticals Inc. have in circulation?
The max supply of Algernon Pharmaceuticals Inc. shares is 21.64M.
What is Algernon Pharmaceuticals Inc. Price to Earnings Ratio (PE Ratio)?
Algernon Pharmaceuticals Inc. PE Ratio is now.
What was Algernon Pharmaceuticals Inc. earnings per share over the trailing 12 months (TTM)?
Algernon Pharmaceuticals Inc. EPS is -0.28 CAD over the trailing 12 months.
Which sector does the Algernon Pharmaceuticals Inc. company belong to?
The Algernon Pharmaceuticals Inc. sector is Healthcare.